Aperio Group’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$218K Buy
+5,380
New +$192K ﹤0.01% 2286
2019
Q3
Sell
-740
Closed -$21K 2555
2019
Q2
$21K Buy
+740
New +$20.6K ﹤0.01% 2686

Other funds holding LMAT

Aperio Group's LMAT Position: Q4 2020 in Review

Aperio Group opened a new position in LeMaitre Vascular (LMAT) in Q4 2020: 5,380 shares worth $218K. The stake represents ﹤0.01% of the portfolio and ranks #2286 among its holdings. This is a return to the name: Aperio Group previously reported a position in LMAT as recently as Q2 2019.

Aperio Group first reported a position in LMAT in Q2 2019 and has held it in 2 quarters since. 179 funds tracked by Wall St. Rank hold LMAT as of Q4 2020.

  • Aperio Group held 5,380 shares of LeMaitre Vascular worth $218K as of Q4 2020.
  • LeMaitre Vascular was a new Aperio Group position in Q4 2020.
  • LeMaitre Vascular made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2286 holding.
  • Aperio Group first reported a position in LeMaitre Vascular in Q2 2019 and has held it in 2 quarters since.
  • 179 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.